These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 12641435)
1. Major intermediates in organophosphate synthesis (PCl3, POCl3, PSCl3, and their diethyl esters) are anticholinesterase agents directly or on activation. Segall Y; Quistad GB; Sparks SE; Casida JE Chem Res Toxicol; 2003 Mar; 16(3):350-6. PubMed ID: 12641435 [TBL] [Abstract][Full Text] [Related]
2. Oxidative bioactivation of methamidophos insecticide: synthesis of N-hydroxymethamidophos (a candidate metabolite) and its proposed alternative reactions involving N-->O rearrangement or fragmentation through a metaphosphate analogue. Mahajna M; Casida JE Chem Res Toxicol; 1998 Jan; 11(1):26-34. PubMed ID: 9477223 [TBL] [Abstract][Full Text] [Related]
3. Phosphoacetylcholinesterase: toxicity of phosphorus oxychloride to mammals and insects that can be attributed to selective phosphorylation of acetylcholinesterase by phosphorodichloridic acid. Quistad GB; Zhang N; Sparks SE; Casida JE Chem Res Toxicol; 2000 Jul; 13(7):652-7. PubMed ID: 10898598 [TBL] [Abstract][Full Text] [Related]
4. Acephate insecticide toxicity: safety conferred by inhibition of the bioactivating carboxyamidase by the metabolite methamidophos. Mahajna M; Quistad GB; Casida JE Chem Res Toxicol; 1997 Jan; 10(1):64-9. PubMed ID: 9074804 [TBL] [Abstract][Full Text] [Related]
5. Blood acylpeptide hydrolase activity is a sensitive marker for exposure to some organophosphate toxicants. Quistad GB; Klintenberg R; Casida JE Toxicol Sci; 2005 Aug; 86(2):291-9. PubMed ID: 15888665 [TBL] [Abstract][Full Text] [Related]
6. Acute toxicity of synthetic Gymnodinium breve toxin metabolite and its analogues in mice. Husain K; Singh R; Kaushik MP; Gupta AK Ecotoxicol Environ Saf; 1996 Oct; 35(1):77-80. PubMed ID: 8930507 [TBL] [Abstract][Full Text] [Related]
7. Effects of acetylcholinesterase and butyrylcholinesterase inhibition on breathing in mice adapted or not to reduced acetylcholinesterase. Boudinot E; Taysse L; Daulon S; Chatonnet A; Champagnat J; Foutz AS Pharmacol Biochem Behav; 2005 Jan; 80(1):53-61. PubMed ID: 15652380 [TBL] [Abstract][Full Text] [Related]
8. Aging-resistant organophosphate bioscavenger based on polyethylene glycol-conjugated F338A human acetylcholinesterase. Mazor O; Cohen O; Kronman C; Raveh L; Stein D; Ordentlich A; Shafferman A Mol Pharmacol; 2008 Sep; 74(3):755-63. PubMed ID: 18523134 [TBL] [Abstract][Full Text] [Related]
9. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity. Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656 [TBL] [Abstract][Full Text] [Related]
10. Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase. Aurbek N; Thiermann H; Szinicz L; Eyer P; Worek F Toxicology; 2006 Jul; 224(1-2):91-9. PubMed ID: 16720069 [TBL] [Abstract][Full Text] [Related]
11. Aging pathways for organophosphate-inhibited human butyrylcholinesterase, including novel pathways for isomalathion, resolved by mass spectrometry. Li H; Schopfer LM; Nachon F; Froment MT; Masson P; Lockridge O Toxicol Sci; 2007 Nov; 100(1):136-45. PubMed ID: 17698511 [TBL] [Abstract][Full Text] [Related]
12. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis. Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953 [TBL] [Abstract][Full Text] [Related]
14. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman. Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090 [TBL] [Abstract][Full Text] [Related]
15. Co-administration of memantine has no effect on the in vitro or ex vivo determined acetylcholinesterase inhibition of rivastigmine in the rat brain. Enz A; Gentsch C Neuropharmacology; 2004 Sep; 47(3):408-13. PubMed ID: 15275830 [TBL] [Abstract][Full Text] [Related]
16. The pH dependence of dealkylation in soman-inhibited cholinesterases and their mutants: further evidence for a push-pull mechanism. Saxena A; Viragh C; Frazier DS; Kovach IM; Maxwell DM; Lockridge O; Doctor BP Biochemistry; 1998 Oct; 37(43):15086-96. PubMed ID: 9790671 [TBL] [Abstract][Full Text] [Related]
17. Modification of acetylcholinesterase during adaptation to chronic, subacute paraoxon application in rat. Milatovic D; Dettbarn WD Toxicol Appl Pharmacol; 1996 Jan; 136(1):20-8. PubMed ID: 8560475 [TBL] [Abstract][Full Text] [Related]
18. Reaction kinetics of biotinylated organophosphorus toxicant, FP-biotin, with human acetylcholinesterase and human butyrylcholinesterase. Schopfer LM; Voelker T; Bartels CF; Thompson CM; Lockridge O Chem Res Toxicol; 2005 Apr; 18(4):747-54. PubMed ID: 15833035 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of huperzine B on cholinesterase activity in mice. Liu J; Zhang HY; Wang LM; Tang XC Zhongguo Yao Li Xue Bao; 1999 Feb; 20(2):141-5. PubMed ID: 10437161 [TBL] [Abstract][Full Text] [Related]